Uterine leiomyoma By the end of their reproductive years, over 50% of women in the United States develop uterine fibroids, making the condition the most prevalent reproductive disorder of women. Despite their prevalence, the condition remains poorly understood. One prominent feature of uterine fibroids is that cells within the tumors produce a disordered and excessive extracellular matrix (ECM). Previously, we have examined the ECM and characteristics of the cells that produce this excessive and fibrotic ECM and have found that mechanical signaling (a method of cell communication and activation) was altered in cells within a fibroid. In the past year we have found that cells that comprise a fibroid have impaired responses (decreased) to mechanical stimuli. Additionally, we completed a collaborative clinical trial led by Drs. Wood, Stratton and Venkatesan of MRI-guided high frequency ultrasound (HIFU) for the non-surgical treatment of uterine fibroids. Assessment and preservation of ovarian function in women and young girls undergoing cancer treatment Because of improved survival and effective chemotherapy for cancers, many young girls and women now are able to survive cancer, but find that reproductive function is impaired. In the past year we have completed animal and clinical investigations with plans to continue additional studies in a pediatric clinical populations and additional animal studies to examine potential mechanism(s) for preservation of primordial follicles after exposure to alkylating agents. We will also continue our study of diminished ovarian reserve in infertility patients. In the past year we reported animal data that suggested GnRH analogues preserve primordial follicles after exposure to the chemotherapy agent, cyclophosphamide. Results suggested that this may be due to a decrease in apoptosis (programmed cell death). In the coming year, we plan to continue to investigate possible mechanism(s) involved. We also plan to begin a clinical study to examine new biomarkers of ovarian reserve in this patient population. Infertility and reproductive health disparities Our unit has continued to conduct studies of infertility and reproductive health disparities. Dr. Armstrong helped to established a Special Interest Group and national research network on the topic of Health Disparities. Investigators in the branch helped to arrange the a new abstract session and symposium this year at the Annual Meeting of the American Society of Reproductive Medicine on this reproductive health disparities. In the past year, Dr. Armstrong also led an NICHD-hosted conference on Health Disparities. In the coming year, we plan to continue to examine ethnic and racial differences in lipids and glucose metabolism. Role of BRX (also known as AKAP13) in cardiac development, immune function and reproduction Our previous studies of the gene BRX (AKAP13), cloned by our group, indicated that this large Rho-GEF protooncoprotein was involved in estrogen and glucocorticoid receptor activation. We previously found that the BRX gene product coordinates G-sub-alpha-s and Rho signaling with an essential transcription program in developing cardiomyocytes in mice, involving myocyte enhancer factor 2 C (MEF2C). Mice with two defective copies of the AKAP13 gene (knockout) died in utero. In the past year we have made progress on development of a conditional gene targeting strategy using the Cre-Lox system in mice. Plans are to examine the phenotypes of the conditionally-targeted offspring. In addition, in the coming year we will examine the phenotypes of mice heterozygous for the AKAP13 null allele to determine whether these mice may have subtle abnormalities in estrogen or glucocorticoid signaling.
| Martini, Anne E; Zolton, Jessica R; DeCherney, Alan H (2018) Isolated Absent Thelarche in a Patient With Neurofibromatosis Type 1 and Acromegaly. Obstet Gynecol 131:96-99 |
| Niederberger, Craig; Pellicer, Antonio; Cohen, Jacques et al. (2018) Forty years of IVF. Fertil Steril 110:185-324.e5 |
| Evans, Michael B; Healy, Mae W; DeCherney, Alan H et al. (2018) Adverse effect of prematurely elevated progesterone in in vitro fertilization cycles: a literature review. Biol Reprod 99:45-51 |
| Carpinello, Olivia; DeCherney, Alan (2018) Old insights, same questions. Fertil Steril 109:807-808 |
| Zolton, Jessica R; Parikh, Toral P; Hickstein, Dennis D et al. (2018) Oocyte cryopreservation for women with GATA2 deficiency. J Assist Reprod Genet 35:1201-1207 |
| Krishnamoorthy, Kavitha; Decherney, Alan H (2017) Genetics of Endometriosis. Clin Obstet Gynecol 60:531-538 |
| Plowden, Torie C; Schisterman, Enrique F; Sjaarda, Lindsey A et al. (2017) Thyroid-stimulating hormone, anti-thyroid antibodies, and pregnancy outcomes. Am J Obstet Gynecol 217:697.e1-697.e7 |
| Heitmann, Ryan J; Hill, Micah J; Csokmay, John M et al. (2017) Embryo transfer simulation improves pregnancy rates and decreases time to proficiency in Reproductive Endocrinology and Infertility fellow embryo transfers. Fertil Steril 107:1166-1172.e1 |
| Hill, Micah J; Royster 4th, G Donald; Taneja, Mansi et al. (2017) Does elevated progesterone on day of oocyte maturation play a role in the racial disparities in IVF outcomes? Reprod Biomed Online 34:154-161 |
| Rafique, Saima; Decherney, Alan H (2017) Medical Management of Endometriosis. Clin Obstet Gynecol 60:485-496 |
Showing the most recent 10 out of 99 publications
